Glen Eagle Advisors’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-20
Closed -$1.24K 1074
2025
Q3
$1.24K Hold
20
﹤0.01% 973
2025
Q2
$1.47K Hold
20
﹤0.01% 880
2025
Q1
$1.73K Hold
20
﹤0.01% 862
2024
Q4
$1.79K Hold
20
﹤0.01% 885
2024
Q3
$2.2K Hold
20
﹤0.01% 895
2024
Q2
$1.93K Hold
20
﹤0.01% 907
2024
Q1
$1.97K Hold
20
﹤0.01% 906
2023
Q4
$1.77K Sell
20
-7
-26% -$558 ﹤0.01% 877
2023
Q3
$2.07K Hold
27
﹤0.01% 855
2023
Q2
$2.26K Hold
27
﹤0.01% 857
2023
Q1
$2.28K Hold
27
﹤0.01% 840
2022
Q4
$2.2K Hold
27
﹤0.01% 858
2022
Q3
$1.92K Hold
27
﹤0.01% 865
2022
Q2
$2.42K Hold
27
﹤0.01% 807
2022
Q1
$3.03K Hold
27
﹤0.01% 765
2021
Q4
$3.27K Hold
27
﹤0.01% 753
2021
Q3
$2.72K Hold
27
﹤0.01% 890
2021
Q2
$3.15K Hold
27
﹤0.01% 867
2021
Q1
$2.97K Hold
27
﹤0.01% 835
2020
Q4
$2.71K Buy
+27
New +$2.5K ﹤0.01% 819
2017
Q4
Sell
-49
Closed -$4.43K 656
2017
Q3
$4.43K Hold
49
﹤0.01% 531
2017
Q2
$4.12K Buy
49
+18
+58% +$1.45K ﹤0.01% 493
2017
Q1
$2.5K Buy
31
+18
+138% +$1.42K ﹤0.01% 505
2016
Q4
$978 Buy
+13
New +$939 ﹤0.01% 519

Other funds holding EMN

Glen Eagle Advisors's EMN Position: Q4 2025 in Review

Glen Eagle Advisors sold out of Eastman Chemical (EMN) in Q4 2025, closing a stake of 20 shares — an estimated $1.24K sold.

Glen Eagle Advisors first reported a position in EMN in Q4 2016 and held it in 24 quarters. The position peaked at $4.43K in Q3 2017. 630 funds tracked by Wall St. Rank hold EMN as of Q4 2025.

  • Glen Eagle Advisors reported no remaining Eastman Chemical position as of Q4 2025 after selling out during the quarter.
  • Glen Eagle Advisors sold 20 Eastman Chemical shares in Q4 2025, an estimated $1.24K.
  • Glen Eagle Advisors first reported a position in Eastman Chemical in Q4 2016 and held it in 24 quarters.
  • Glen Eagle Advisors's Eastman Chemical position peaked at $4.43K in Q3 2017.
  • 630 funds tracked by Wall St. Rank held Eastman Chemical as of Q4 2025.

Based on Glen Eagle Advisors's 13F filing for Q4 2025, filed 13 Feb 2026.